Montreal – April 29, 2026 | McGill University’s DNA to RNA Initiative (D2R) has invested nearly $6 million in funding to support four groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on April 23-24, 2026.
Category:
Published on: 29 Apr 2026
Pilot project at the Jewish General Hospital aims to accelerate access to new and highly effective treatments for cancer patients
Montreal, September 5, 2023 - A pilot project led by the Jewish General Hospital proposes a new promising approach to cancer treatment known as data-based precision oncology to accelerate access to new and highly effective treatments for cancer patients. This innovative strategy involves tailoring cancer treatments based on intricate details unique to each patient's tumor.
Category:
Published on: 5 Sep 2023
